摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dihydrokopsingine | 163081-74-1

中文名称
——
中文别名
——
英文名称
dihydrokopsingine
英文别名
dimethyl (1S,9R,16S,17R,18R,21R)-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-2,18-dicarboxylate
dihydrokopsingine化学式
CAS
163081-74-1
化学式
C24H30N2O7
mdl
——
分子量
458.511
InChiKey
HFFFKDJIGLVQMK-BAQUWZKJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    33
  • 可旋转键数:
    4
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    109
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    dihydrokopsingine2,6-二甲基吡啶高氯酸四乙基铵 作用下, 以 二氯甲烷乙腈 为溶剂, 以20%的产率得到dimethyl (1R,2R,6R,14S,15R,16R,18S)-15-hydroxy-11-methoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.01,16.02,6.03,18.06,14.07,12]docosa-7(12),8,10-triene-13,15-dicarboxylate
    参考文献:
    名称:
    Kopsia的Aspidofractinine型生物碱对心血管的影响。
    摘要:
    静脉注射来自Kopsia teoi的Aspidofractinine生物碱kopsingine(1,0.2-10.0 mg / kg)在麻醉的自发性高血压大鼠中导致平均动脉血压和心率的剂量相关降低,这与在正常血压中观察到的相似控件。像kopsaporine(2,即kopsingine的12-去甲氧基衍生物)和14,15-dihydrokopsingine(4)那样,对kopsingine的分子结构进行了较小的修饰,并未显着改变降压反应,而结构上的变化更为剧烈,如在七环甲酚A(3)和3到17氧代桥联化合物5中一样,导致血压升高。
    DOI:
    10.1021/np9703712
  • 作为产物:
    描述:
    kopsingine 在 palladium on activated charcoal 氢气 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以100%的产率得到dihydrokopsingine
    参考文献:
    名称:
    Kopsia的Aspidofractinine型生物碱对心血管的影响。
    摘要:
    静脉注射来自Kopsia teoi的Aspidofractinine生物碱kopsingine(1,0.2-10.0 mg / kg)在麻醉的自发性高血压大鼠中导致平均动脉血压和心率的剂量相关降低,这与在正常血压中观察到的相似控件。像kopsaporine(2,即kopsingine的12-去甲氧基衍生物)和14,15-dihydrokopsingine(4)那样,对kopsingine的分子结构进行了较小的修饰,并未显着改变降压反应,而结构上的变化更为剧烈,如在七环甲酚A(3)和3到17氧代桥联化合物5中一样,导致血压升高。
    DOI:
    10.1021/np9703712
点击查看最新优质反应信息

文献信息

  • Unprecedented Cyanation and Cyanomethylation Following Ring Closure versus Dimer Formation during Anodic Oxidation of the Aspidofractinine Alkaloid Kopsamine
    作者:Toh-Seok Kam、Tuck-Meng Lim、Guan-Huat Tan
    DOI:10.3987/com-98-8400
    日期:——
    Anodic oxidation of the aspidofractinine-type indole alkaloid kopsamine on platinum in Et4NClO4/MeCN results in an unprecedented cyanation-cynomethylation reaction following ring closure while oxidation on vitreous carbon in LiClO4-MeOH yielded a dimerization product with a C-2 element of symmetry.
  • Electrochemical oxidation of aspidofractinine-type indole alkaloids. A facile, electrochemically-mediated conversion of kopsingine to kopsidines A, B, C, and kopsinganol
    作者:Guan-Huat Tan、Tuck-Meng Lim、Toh-Seok Kam
    DOI:10.1016/0040-4039(94)02468-q
    日期:1995.2
    Kopsidine A, B, C and kopsinganol,were synthesised from kopsingine in good yields via the stable imminium salt obtained from electrochemical oxidation of kopsingine. Electrooxidation of dihydrokopsingine on the other hand gave the 17-to-5 and 17-to-3 oxo-bridged alkaloids directly, while 3-oxokopsingine was inert to electrooxidation in the potential range employed.
查看更多

同类化合物

蕊木宁F 蕊木宁 柯蒲木酮碱 夾竹桃鹼 (3aR,5R,5aR,10bR,13aS)-6-甲酰基-2,3,4,5,11,12-六氢-6H,13ah-3a,5a-乙桥-1H-吲哚嗪并[8,1-cd]咔唑-5-羧酸甲酯 (2a,3b,5a,6a,7a,20S)-6,7-环氧-20-羟基-白坚木替宁-3-羧酸甲酯 (2R,5S)-6alpha,7alpha-环氧白坚木替宁-3beta-羧酸甲酯 (2R,5R)-6,7-二去氢白坚木替宁-3beta-羧酸甲酯 N(a),11α-Bis-methoxycarbonyl-3β-hydroxy-aspidofraktinin (-)-N(a)-Acetyl-3-oxo-aspido-fraktinin N(a)-Methoxycarbonyl-3-oxo-aspido-fraktinin kopsinganol N(a),11α-Dimethoxycarbonyl-aspidofraktinin Methyl-18-O-tetrahydropyran-2-yl-reserpat-N-oxid kopsiloscine A N-Acetyl-14,15-dihydro-vindolinin Kopsin-aethylenketal Majorininacetat 2-ethoxy-5-hydroxy-8-oxo-3,4-didehydro-20,21-dinor-aspidospermidine-1-carboxylic acid ethyl ester 5-hydroxy-8-oxo-2,3-didehydro-20,21-dinor-aspidospermidine-1-carboxylic acid ethyl ester danuphylline B 16-Epi-19-oxokopsinin 18-acetoxy-17-methoxy-benzo[9,10]yohimb-3(14)ene-16-carboxylic acid methyl ester (+)-dideepoxytabernaebovine kopsijasmine methyl (5aS,8aR,9aS,9a1S,15aR)-9a-ethyl-7-oxo-6,7,9a,9a1,11,12,14,15-octahydro-5H,10H-indolizino[8,1-cd]oxazolo[4,5-m]carbazole-8a(9H)-carboxylate 3,22-dihydroxy-10-oxo-kopsane-1-carboxylic acid methyl ester Demethoxycarbonyl-kopsin Methyl 3-hydroxy-22-oxokopsan-1-carboxylate Kopsinan rac-(3aR,3a1S,5aR,10bR)-6-(but-1-en-2-yl)-3a1-methyl-5,12-dimethylene-2,3,3a1,4,5,11,12,12a-octahydro-1H,6H-3a,5a-ethanoindeno[7,1-cd]fluorene 1-Carbomethoxy-10-oxo-3-hydroxykopsinine carboxaldehyde 1-Carbomethoxy-10-oxokopsinoic acid 1-Carbomethoxy-3-decarbomethoxy-10-oxo-3-hydroxykopsininecarbinol 1-Carbomethoxy-3-decarbomethoxy-10-oxokopsininecarbinol meso-di-tert-butyl-7,7′-dibromo-1,1′-dimethyl-1,1′,2,2′,3,3a,3′,3′a-octahydro-3a,3′a-bipyrrolo[2,3-b]indole-8,8′(8aH,8′aH)-dicarboxylate Isokopsin N-Acetyl-aspidofraktinin Kopsin-jodmethylat 3-oxo-(Na-tert-butoxycarbonyl)tabersonine methyl (2β,11β,12β,19α)-21-oxo-11,21-cycloaspidospermidine-2-carboxylate 4,5-Diacetoxy-3a-ethyl-8-methoxy-5-methoxycarbonyl-6-methyl-3a,4,5,5a,6,11,12,12b-octahydro-6-aza-12a-azonia-indeno[7,1-cd]fluorene N(a)-Methyl-hopsinal 3-hydroxy-10,22-dioxo-kopsane-1-carboxylic acid methyl ester (+/-)-kopsanone (+/-)-16,17-didehydropleiocarpinine (–)-kopsifoline D hydrate 1-deuterio-aspidofractinin-4(or 20)-one 1-carbomethoxy-17-oxoaspidofractinine